NanoSanguis
NanoGroup is an innovative biotechnology company specializing in nanotechnology and nanomedicine. Its mission is to develop new medical technologies to improve the effectiveness and safety of therapies, with a focus on human blood substitutes and targeted cancer treatments. The company is engaged in research, development, and commercialization of projects protected by patents worldwide, collaborating with international research institutes and maintaining subsidiaries in the biotech sector. It actively participates in international development, builds partnerships in the Gulf region, and is involved in innovative projects and research in transplantation and nanotechnology.
Industries
Nr. of Employees
small (1-50)
NanoSanguis
ul. Rakowiecka 36, 02-532 Warszawa, Poland
Products
Integrated ex vivo organ perfusion system (device and perfusate)
Integrated system combining a perfusion device with dedicated oxygenating perfusion fluid to preserve, oxygenate and support regeneration of organs outside the body across a range of temperatures.
Oxygen-carrying perfusate and blood-substitute formulations
Fluid formulations based on oxygen-carrying nanoemulsions intended to oxygenate tissues or act as blood-substitute research fluids.
Polysaccharide nanoparticle platforms for targeted oncology
Nanoparticle platforms based on polysaccharides for encapsulation and targeted delivery of chemotherapeutic agents to tumors, designed to improve circulation time and reduce systemic toxicity.
Radiolabeled nanoparticle agents for diagnostic and theranostic use
Nanoparticle formulations intended to carry radioisotopes for early detection of disease and potential theranostic applications.
Antibody-fragment-conjugated polymer nanosystems for CNS delivery
Polymer-based nanosystems conjugated with antibody fragments designed to cross the blood–brain barrier and deliver therapeutics to central nervous system targets.
Integrated ex vivo organ perfusion system (device and perfusate)
Integrated system combining a perfusion device with dedicated oxygenating perfusion fluid to preserve, oxygenate and support regeneration of organs outside the body across a range of temperatures.
Oxygen-carrying perfusate and blood-substitute formulations
Fluid formulations based on oxygen-carrying nanoemulsions intended to oxygenate tissues or act as blood-substitute research fluids.
Polysaccharide nanoparticle platforms for targeted oncology
Nanoparticle platforms based on polysaccharides for encapsulation and targeted delivery of chemotherapeutic agents to tumors, designed to improve circulation time and reduce systemic toxicity.
Radiolabeled nanoparticle agents for diagnostic and theranostic use
Nanoparticle formulations intended to carry radioisotopes for early detection of disease and potential theranostic applications.
Antibody-fragment-conjugated polymer nanosystems for CNS delivery
Polymer-based nanosystems conjugated with antibody fragments designed to cross the blood–brain barrier and deliver therapeutics to central nervous system targets.
Services
Design and conduct of in vivo and ex vivo preclinical experiments including organ perfusion, autotransplantation and post-transplant monitoring with associated sample analytics.
Prototype development, component standardization and iterative testing of perfusion hardware, control electronics and device software for organ support applications.
Formulation services for encapsulating small-molecule therapeutics into polysaccharide nanoparticles, including in vitro characterization and in vivo performance testing.
Development of biopolymer nanoparticle carriers for radioisotope delivery aimed at diagnostic imaging and potential theranostic applications.
Execution of outsourced research projects and support for early-stage commercialization, licensing and external validation through third-party collaborators.
Preparation, coordination and administration of grant-funded research projects and participation in joint consortium activities for translational programs.
Design and conduct of in vivo and ex vivo preclinical experiments including organ perfusion, autotransplantation and post-transplant monitoring with associated sample analytics.
Prototype development, component standardization and iterative testing of perfusion hardware, control electronics and device software for organ support applications.
Formulation services for encapsulating small-molecule therapeutics into polysaccharide nanoparticles, including in vitro characterization and in vivo performance testing.
Development of biopolymer nanoparticle carriers for radioisotope delivery aimed at diagnostic imaging and potential theranostic applications.
Execution of outsourced research projects and support for early-stage commercialization, licensing and external validation through third-party collaborators.
Preparation, coordination and administration of grant-funded research projects and participation in joint consortium activities for translational programs.
Expertise Areas
- Organ perfusion and preservation
- Nanoparticle drug delivery and nanoformulations
- Radiopharmaceutical carrier design and preclinical validation
- Preclinical study design and large-animal transplant models
Key Technologies
- Polysaccharide-based nanoparticles (dextran-derived)
- Perfluorocarbon nanoemulsions for oxygen transport
- Ex vivo organ perfusion systems and perfusates
- Radiolabeling techniques for nanoparticle biodistribution